A breakthrough in the quest to find a blood test for Alzheimer's will help doctors and patients "manage the disease", one of the researchers has said.
Professor Howard Federoff explained:
Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder.
The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention.
Biomarkers such as ours that define this asymptomatic period are critical for successful development and application of these therapeutics.
We consider our results a major step toward the commercialisation of a preclinical disease biomarker test.
More top news
The controversial extraction method has given some an economic lifeline but others say it has ruined the tranquility of the area.
After unseasonably windy weather today with gales and big battering waves along exposed western coastal spots a little calmer into tomorrow
A man who has been called a Godfather of football hooliganism by police has been banned from every ground in the country for five years.